Para a página inicial
820К+ pacientes receberam assistência desde 2014
50 países
1,500 clínicas
6K+ avaliações
3K+ médicos qualificados

Qual é o custo para procedimentos de diagnóstico e tratamento de Linfoma não-Hodgkin em Polónia? Descubra agora

O preço é fornecido sob solicitação
PolóniaTurquiaÁustria
Transplante de medula ósseade $80,000de $36,000de $140,000
Transplante autólogo de medula ósseade $30,000de $31,500de $50,000
Transplante alogénico de medula óssea de dador relacionadode $75,000de $65,000de $150,000
Transplante alogénico de medula óssea de dador não relacionadode $100,000de $80,000de $180,000
Terapia de radiação para o cancro colorretalde $8,000de $7,000de $12,000
Dados verificados pela Bookimed em June 2026, com base em solicitações de pacientes e cotações oficiais de 75 clínicas em todo o mundo. Os custos medianos são baseados em faturas reais (2025–2026) e atualizados mensalmente. Os preços reais podem variar.

Seus Benefícios e Garantias com a Bookimed

Preços Diretos

A Bookimed não adiciona taxas extras aos preços de tratamento de Linfoma não-Hodgkin. As tarifas vêm das listas oficiais de preços das clínicas. O pagamento é feito diretamente na clínica na chegada ao país.

Somente Clínicas e Médicos Verificados

A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais no tratamento de Linfoma não-Hodgkin e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.

Assistência gratuita 24/7

A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de tratamento de Linfoma não-Hodgkin.

Por que nós?

Seu assistente Bookimed pessoal

  • Apoia em cada etapa
  • Ajuda a escolher clínica e médico adequados
  • Garante acesso rápido e conveniente à informação

Compartilhar este conteúdo

Histórias em vídeo de pacientes da Bookimed

Dayana
I combined my vacation in Antalya with a check-up.
Procedimento: Check-up feminino
Igor
It was great! Transfers, accommodation, treatment—all included.
Procedimento: Implante Dentário
Clínica: WestDent Clinic
Marina
Bookimed did everything for me. I didn't have to worry about anything.
Procedimento: Check-up feminino
Atualizado: 05/27/2022
Autoria de
Anna Leonova
Anna Leonova
Chefe da Equipe de Marketing de Conteúdo
Redator médico certificado com mais de 10 anos de experiência, desenvolveu o conteúdo confiável do Bookimed, apoiado por Mestrado em Filologia e entrevistas com especialistas médicos em todo o mundo.
Fahad Mawlood
Editor médico e cientista de dados
Clínico geral. Vencedor de 4 prêmios científicos. Atuou na Ásia Ocidental. Ex-líder de equipe médica que atendia pacientes de língua árabe. Agora responsável pelo processamento de dados e precisão do conteúdo médico.
Fahad Mawlood Linkedin
Esta página pode conter informações relacionadas a várias condições médicas, tratamentos e serviços de saúde disponíveis em diferentes países. O conteúdo é fornecido apenas para fins informativos e não deve ser interpretado como orientação ou aconselhamento médico. Consulte um médico ou profissional de saúde qualificado antes de iniciar ou alterar qualquer tratamento médico.

FAQ sobre Tratamento de Linfoma não-Hodgkin em Polónia

Estas Perguntas Frequentes provêm de pacientes reais que procuram assistência médica através da Bookimed. As respostas são dadas por coordenadores médicos experientes e representantes de confiança das clínicas.

What are the primary treatment methods available for Non-Hodgkin's lymphoma in Poland?

Polish oncology centers treat Non-Hodgkin lymphoma using chemoimmunotherapy, targeted molecular drugs, and radiation. Genetic testing and bone marrow biopsies guide these protocols. High-volume academic hospitals provide advanced interventions. These include hematopoietic stem cell transplantation and CAR-T cell therapy for relapsed cases.

  • Systemic therapy: Doctors prioritize R-CHOP chemoimmunotherapy for aggressive B-cell lymphoma variants.
  • Targeted drugs: Protocols include BTK and BCL2 inhibitors for refractory lymphoid malignancies.
  • Stem cell transplant: Specialist units perform autologous and allogeneic transplants for high-risk patients.
  • Radiation therapy: Localized radiation targets early-stage disease or consolidated bulky tumor masses.

Bookimed Expert Insight: Patient volume is a major indicator of technical capacity in Poland. The University Hospital in Krakow treats over 455,000 patients annually. This massive scale ensures surgeons and hematologists maintain high proficiency in complex transplant protocols. Centers with such high turnover typically house the most advanced diagnostic equipment.

Patient Consensus: Patients note that getting a second pathology opinion is vital before starting treatment. They emphasize that treatment feels very center-based, often requiring travel to major city hematology units.

Can patients access novel targeted therapies or clinical trials in Poland?

Patients access novel targeted therapies and clinical trials in Poland through specialized National Health Fund programs and specialized research networks. Major academic centers in cities like Krakow offer early access to pipeline drugs. These treatments are often available before formal market authorization through international oncology trials.

  • Specialized infrastructure: Research centers utilize specialized Clinical Trial Support Centres for enrollment.
  • Reimbursed drug programs: The National Health Fund covers innovative immunotherapies for qualifying patients.
  • Diagnostic fast-track: Patients use the DiLO card system to bypass standard waiting times.
  • Treatment hubs: Large centers like University Hospital in Krakow treat 455,000 patients annually.

Bookimed Expert Insight: Clinical trial entry often bypasses standard reimbursement hurdles in Poland. Our data indicates that large academic centers like the University Hospital in Krakow integrate research directly into care. These institutions house over 100 departments, making them more likely to manage complex hematology trials than local clinics.

Patient Consensus: Patients note that being treated at a large city center is essential for trial access. They emphasize that self-advocacy and requesting second opinions from specialists in Warsaw or Krakow often reveals more treatment options.

Which Polish centers are recognized for lymphoma treatment and clinical research?

Poland hosts leading hematology centers recognized for lymphoma treatment and active clinical research. Key facilities include the University Hospital in Krakow. Warsaw functions as the primary hub for complex cases. These institutions integrate academic research with advanced diagnostic protocols and targeted therapies.

  • Krakow expertise: Krakow University Hospital manages 455,000 yearly patients with 1,000+ doctors.
  • Academic centers: Hospitals in Gdansk and Wroclaw lead the Polish Lymphoma Research Group.
  • Advanced therapies: Wroclaw specializes in academic in-house CAR-T cell therapy for aggressive lymphoma.
  • Precision diagnostics: Specialist centers in Poznan utilize molecular genetics and CyberKnife radiation technology.

Bookimed Expert Insight: Lymphoma care in Poland follows a clear hub-and-spoke model centered on academic volume. Organizations like the University Hospital in Krakow serve over 450,000 patients annually. This massive scale ensures doctors see rare lymphoma subtypes daily. Facilities with high patient volumes often house the specialized equipment needed for precise immunophenotyping. Research suggests these academic centers provide the fastest path to innovative clinical trials.

Patient Consensus: Patients emphasize that getting a second opinion on pathology at a major academic center is vital. They often prefer clinics that offer quick access to PET/CT scans and molecular testing.

Are Polish hospitals formally accredited for international patient safety standards?

Polish hospitals maintain formal accreditation through domestic frameworks aligned with international benchmarks. Facilities follow Ministry of Health standards managed by the Center for Health Quality Monitoring. These mimic Joint Commission International protocols. Most clinics also adhere to strict European Union safety directives for patient care.

  • National accreditation: The Center for Health Quality Monitoring manages standards based on global models.
  • EU regulations: All facilities must comply with rigorous European Union safety and hygiene laws.
  • Quality management: Major medical centers frequently hold ISO 9001 certifications for healthcare risk management.
  • Academic oversight: University hospitals like University Hospital in Krakow provide specialized care for 455,000+ patients.

Bookimed Expert Insight: Poland ranks fifth globally for patient requests in our system. This high volume suggests a strong trust in their medical infrastructure. Large academic centers like University Hospital in Krakow manage over 100 departments. These massive institutions often provide more comprehensive safety protocols than smaller private clinics for complex blood cancers.

Patient Consensus: Patients note that a hospital's status as a specialized hematology center matters more than labels. They emphasize verifying the speed of pathology reviews and ensuring the clinical team speaks English fluently.

What medical records must international patients bring before traveling to Poland for lymphoma care?

International patients traveling to Poland for lymphoma treatment must bring original pathology materials, diagnostic imaging on digital media, and detailed biopsy reports. Polish hematologists require glass slides and paraffin blocks for mandatory diagnostic verification. Translated medical summaries in English or Polish ensure rapid clinical qualification for specialized care.

  • Pathology materials: Bring original glass slides and blocks for expert second review.
  • Imaging data: Provide CT, PET-CT, and MRI scans in DICOM format on USB.
  • Treatment history: Include chemotherapy dosages, cycle dates, and radiation therapy protocols.
  • Laboratory results: Gather blood counts, biochemistry panels, and tumor markers in chronological order.

Bookimed Expert Insight: Poland offers high-capacity care, with University Hospital in Krakow treating 455,000 patients annually. Large centers like this prioritize raw data over summaries. Having original DICOM files and pathology tissue allows their 1,000+ specialized doctors to verify subtypes without repeating invasive procedures. Check if your scans include reports for comparison to confirm disease progression speed.

Patient Consensus: Patients note it is critical to bring original tissue samples as diagnosis can change after a second review. They emphasize that summaries alone cause delays while clinics request original files.

How long should one plan to stay in Poland for lymphoma treatment?

Patients should plan to stay in Poland for 4 to 6 months for full chemotherapy. Radiation therapy typically requires 2 to 6 weeks near the clinic. Stem cell transplants demand a much longer stay of 6 to 12 months. This ensures safe recovery as the immune system remains fragile.

  • Chemotherapy cycles: Most treatments repeat every 2 to 4 weeks for several months.
  • Diagnostic phase: Initial pathology and PET-CT staging usually take 7 to 14 days.
  • High-risk window: Patients must remain localized during days 7 to 14 of each cycle.
  • Transplant recovery: Intensive inpatient monitoring often lasts 4 to 8 weeks after the procedure.

Bookimed Expert Insight: University Hospital in Krakow manages 455,000 patients yearly across 103 specialized departments. Our data shows that large academic centers like this provide a safety net for complex cases. They offer specialized hematology labs and on-site blood banks. This infrastructure helps avoid delays when patients need urgent transfusions or sudden diagnostic repeats.

Patient Consensus: Many find the diagnostic stage takes several days longer than expected for subtype confirmation. Patients suggest bringing physical copies of all previous pathology and PET-CT reports to speed up the process.

Is language support available for non-Polish-speaking patients?

Language support for non-Polish-speaking patients is widely available in private centers and large urban hospitals. Private oncology clinics often provide English-speaking coordinators and medical interpreters. Major systems like Lux Med and Medicover employ fluent staff. Public facilities have variable English support for administrative tasks.

  • Coordinator support: Private networks offer dedicated English-speaking managers for treatment navigation.
  • Doctor communication: Most oncologists in major cities speak basic or fluent English.
  • Administrative barriers: Reception and scheduling staff in public hospitals rarely speak English.
  • Language availability: Translation for specific dialects is often provided for international protection cases.

Bookimed Expert Insight: Poland ranks fifth globally for medical requests in our network, reflecting high international patient volume. Academic centers like the University Hospital in Krakow manage over 455,000 patients annually. These high-volume hubs are more likely to have multilingual staff but may require a personal translator for administrative steps. We recommend choosing centers with over 1,000 doctors to increase the likelihood of finding a language-compatible specialist.

Patient Consensus: Patients note that while doctors often speak English, the `in-between` communication with nurses and pharmacists is usually in Polish. It is highly recommended to bring a translation app or a local friend for pharmacy stops and appointment scheduling.

Obtenha uma consulta gratuita

Selecione a melhor forma de contato